Beta Bionics BBNX
NASDAQ BBNX
$19.48 -0.53 (-2.65%)
At close: Aug 20, 2026 · 4:00 PM EDT

Beta Bionics (BBNX) Inventory Average (2025 - 2026)

Beta Bionics (BBNX) posted Inventory Average of $23.8 million for Q2 2026, up 4.83% sequentially from $22.7 million in Q1 2026, and up 44.15% YoY from $16.5 million in Q2 2025.

Beta Bionics (BBNX) Inventory Average (2025 - 2026) Analysis & Trends

Beta Bionics has reported Inventory Average for 2 years, with the latest figure at $23.8 million in Q2 2026.

  • Quarterly Inventory Average rose 44.15% year-over-year to $23.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $23.8 million (up 44.15% YoY) and the FY2025 annual result came in at $17.5 million, up 140.59% from the prior year.
  • Inventory Average advanced to $23.8 million in Q2 2026 per BBNX's latest filing, from $22.7 million in the prior quarter.
  • Over five years, Inventory Average peaked at $23.8 million in Q2 2026 and troughed at $14.5 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 7.15 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 5.47 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 6.13 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 3.18 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 1.13 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 710.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 2.42 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 3.69 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 671.95 Mn
10 Beta Bionics 865.29 Mn 684.80 Mn 18.90 Mn 23.82 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 23.82 Mn
Mar 31, 2026 22.72 Mn
Dec 31, 2025 21.05 Mn
Sep 30, 2025 18.85 Mn
Jun 30, 2025 16.53 Mn
Mar 31, 2025 14.53 Mn